Location: Home
  • search
  • go
  • Relate News
  • 9/2/2024Navigator Medicines Announces $100M Series A Financing and In-Licensin...
  • 8/30/2024Jacobio Out-licensed KRAS G12C Inhibitor Glecirasib and SHP2 Inhibitor...
  • 8/30/2024HUTCHMED Pulls Regulatory Submission for Takeda-Partnered Cancer Drug ...
  • 8/30/2024Virogin Biotech Won Chinese Breakthru Therapy Deisgnation for HCC Drug...
  • 8/30/2024NMPA Suspends Import, Sales and Use of Dr. Reddy's Atomoxetine Hcl Cap...
  • 8/30/2024CDE Issues the List of Reference Formulations for GQCE Studies (82nd B...
  • 8/30/2024Recent Executive Moves
  • 8/30/2024Regional Price Differences of Medical Services: Evidence from China (B...
  • 8/29/2024Pharmaceutical Patent Disputes in China | The Nuances of "Offer to Sel...
  • 8/29/2024CDE Solicits Comments on Draft of the Technical Guidelines for Non-Cli...
  • 8/29/2024U.S. Government Funding Yields Over 1,000 Patents for China-Based Rese...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Clinical Develop...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Eff...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 8/28/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...
  • 8/28/2024Mundipharma Fails to Sell China Unit for the Second Time Amidst High V...
  • 8/27/2024NHSA Issues the List of Drugs Passing Preliminary Form Evaluation for ...
  • 8/27/2024Legend Biotech Wins Chinese Approval of CAR-T Carvykti (Cilta-cel)
  • 8/27/2024Sanofi Suspends Supply and Sale of Flu Vaccine in China
  • 8/27/2024BrightGene Announces Positive Phase II Results for Diabetes Drug BGM05...
  • 8/27/2024Hengrui Secures Chinese Approval of IL-17A mAb, Vunakizumab
  • 8/27/2024Duality Biothera Seeks Hong Kong IPO to Advance BioNTech-Collaborated ...
  • 8/27/2024China Proposed New Anti-Monopoly Guidelines for the Pharmaceutical Sec...
  • 8/26/2024UCB Sells Chinese Neurology and Allergy Business for $680M
  • 8/26/2024Akeso Biopharma Registers New Phase III Clinical Trial for AK112 in Ch...
  • 8/26/2024BeiGene's BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/S...
  • 8/26/2024CDE Solicits Comments on Draft Implementation Suggestions and Chinese ...
  • 8/26/2024CDE Solicits Public Comments on the Guidelines for Writing Clinical-Re...
  • 8/26/2024CDE Solicits Public Comments on the Technical Guidelines for Pharmaceu...
  • 8/26/2024CDE Solicits Public Comments on the Technical Guidelines for Pharmaceu...
  • Page:51/774 Total number of articles:23207: [First][<<] [49] [50] [51] [52] [53] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group